GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Return-on-Tangible-Asset

BMNDF (Biomind Labs) Return-on-Tangible-Asset : -252.25% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Biomind Labs's annualized Net Income for the quarter that ended in Sep. 2024 was $-0.14 Mil. Biomind Labs's average total tangible assets for the quarter that ended in Sep. 2024 was $0.06 Mil. Therefore, Biomind Labs's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2024 was -252.25%.

The historical rank and industry rank for Biomind Labs's Return-on-Tangible-Asset or its related term are showing as below:

BMNDF' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1453.64   Med: -241.64   Max: -171.35
Current: -848.13

During the past 3 years, Biomind Labs's highest Return-on-Tangible-Asset was -171.35%. The lowest was -1453.64%. And the median was -241.64%.

BMNDF's Return-on-Tangible-Asset is ranked worse than
97.67% of 1499 companies
in the Biotechnology industry
Industry Median: -36.14 vs BMNDF: -848.13

Biomind Labs Return-on-Tangible-Asset Historical Data

The historical data trend for Biomind Labs's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Return-on-Tangible-Asset Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23
Return-on-Tangible-Asset
-171.36 -228.20 -1,462.58

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -376.12 -937.93 -1,012.24 -1,294.66 -252.25

Competitive Comparison of Biomind Labs's Return-on-Tangible-Asset

For the Biotechnology subindustry, Biomind Labs's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomind Labs's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Return-on-Tangible-Asset falls into.


;
;

Biomind Labs Return-on-Tangible-Asset Calculation

Biomind Labs's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-1.192/( (0.089+0.074)/ 2 )
=-1.192/0.0815
=-1,462.58 %

Biomind Labs's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=-0.14/( (0.058+0.053)/ 2 )
=-0.14/0.0555
=-252.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data.


Biomind Labs  (OTCPK:BMNDF) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Biomind Labs Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.